Trial Profile
A Double-blind, Randomised, Placebo- and Active-controlled Multiple-dose Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetics Following a Levodopa/Carbidopa 100/25 mg Single-dose in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Aug 2015
Price :
$35
*
At a glance
- Drugs Opicapone (Primary) ; Entacapone; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Bial
- 20 Jun 2013 Results presented at the 17th International Congress of Parkinson's Disease and Movement Disorders.
- 01 Feb 2012 New trial record